Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score

Limited evidence exists on the clinical and economic burden of advanced fibrosis in patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) due to the invasiveness of liver biopsies for accurately staging liver disease. The fibrosis‐4 (FIB‐4) score allows for noninva...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Stuart C., Kachru, Nandita, Parker, Emily, Korrer, Stephanie, Ozbay, A. Burak, Wong, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327220/
https://www.ncbi.nlm.nih.gov/pubmed/32626832
http://dx.doi.org/10.1002/hep4.1524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327220/
https://www.ncbi.nlm.nih.gov/pubmed/32626832
http://dx.doi.org/10.1002/hep4.1524

Ejemplares similares